Virtus Investment Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$441K Buy
3,883
+721
+23% +$82K 0.15% 203
2025
Q1
$332K Buy
+3,162
New +$332K 0.09% 234